跳至主要内容
临床试验/NCT01078493
NCT01078493撤回1 期

Phase 1 Study of Intradermal Injection of Autologous Platelet Rich Plasma for Facial Wrinkles

Novena Medical Center1 个研究点 分布在 1 个国家开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
发起方
试验地点
1
主要终点
Total Wrinkle Length

研究概览

简要总结

Wrinkles result from imperfect repair of the dermal layer resulting in loss of collagen commonly due to ageing, smoking and sun exposure. Platelet rich plasma (PRP) contains a host of growth factors, which have been used in other clinical trials for various medical conditions such as tendonitis, and also in surgery such as the surgical repair of facial defects. Results from these clinical trials suggest that PRP helps in collagen formation and organisation to promote healing of tissues. This study attempts to document the clinical effects of intradermal injection of PRP on wrinkles.

详细描述

10 selected participants will have 10 ml of blood removed for platelet extraction with MyCells®. The resulting Platelet rich plasma will be injected intradermally into the facial wrinkles.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adults more than 21 years of age
  • •Dis-satisfied or anxious about facial wrinkles (total wrinkle length more than 1cm)

排除标准

  • •Pregnant women.
  • •Psychiatric patients.
  • •Known bleeding disorders such as platelet dysfunction syndrome, thrombocytopenia, hypofibrinogenemia
  • •Anticoagulants(eg.aspirin, warfarin)
  • •Had other wrinkle therapy for less than a month.(laser, peels, injections)
  • •Had facelift surgery for less than a year.
  • •Diseased states such as organ failure, severe anaemia, cancer, acute/chronic infections.
  • •Involved in personal litigation against an aesthetic service provider

结局指标

主要结局

Total Wrinkle Length

时间窗: 3 months

All visible wrinkles are measured and the length is summed up to give the Total Wrinkle Length. Comparison of pre treatment and post treatment Total Wrinkle Length will be studied.

次要结局

  • Side effect / Adverse Event(3 months)

研究者

发起方
Novena Medical Center
申办方类型
Network

研究点 (1)

Loading locations...

相似试验